Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Hexyl/methyl aminolevulinate photodynamic therapy does not damage cervical tissue

July 21, 2010

Ziopharm begins phase III palifosfamide trial in metastatic soft tissue sarcoma

July 21, 2010

Geron begins phase II imetelstat trial in advanced non-small cell lung cancer

July 20, 2010

Jevtana launched in U.S. for metastatic hormone-refractory prostate cancer

July 20, 2010

Health Canada clears phase III ReoT3D trial in head and neck cancer

July 20, 2010

FDA approves Lorus Therapeutics' IND for anticancer agent LOR-253

July 20, 2010

Amgen's denosumab BLA receives FDA priority review status

July 19, 2010

Chinese scientists identify novel protein kinase inhibitors

July 19, 2010

Merck KGaA identifies new tyrosine kinase inhibitors

July 16, 2010

FDA grants orphan drug status to Keryx's perifosine for neuroblastoma

July 16, 2010

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...